Fundraising September 15, 2024 – October 1, 2024 About fundraising

Killer Commodities: Public Health and the Corporate...

Main
Medicine
Killer Commodities: Public Health and...

Killer Commodities: Public Health and the Corporate Production of Harm

Hans Baer

0 / 0

How much do you like this book?

What’s the quality of the file?

Download the book for quality assessment

What’s the quality of the downloaded files?

Killer Commodities addresses the impact of harmful products on consumers throughout the world. These case studies highlight the processes of production and marketing of these products, as well as the nature of relevant public health policies.

Categories:

Year:

2008

Edition:

1

Publisher:

AltaMira Press

Language:

english

Pages:

438

ISBN 10:

0759112401

ISBN 13:

9780759112407

File:

PDF, 1.23 MB

IPFS:

,

english, 2008

Read Online

Conversion to is in progress

Conversion to is failed

You may be interested in

Critser, Greg — Generation Rx: how prescription drugs are transforming American lives, minds, and bodies

Nancy Harvey Steorts, Jeanne Benas — Safety and you

John Abramson — Sickening; How Big Pharma Broke American Health Care and How We Can Repair It

Schweitzer, Stuart O. & Lu, Z. John — Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems

Joseph Dumit — Drugs for Life: How Pharmaceutical Companies Define Our Health

David & Eddings, Leigh — De dromers 04 - De Jonge Goden

United States — Office of Technology Assessment. Pharmaceutical R And D: Costs, Risks And Rewards

Schweitzer, Stuart O — Pharmaceutical economics and policy

Donald W. Light — The risks of prescription drugs

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Donald Light (editor) — The Risks of Prescription Drugs

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Karen F. Greif, Jon F. Merz — Current Controversies in the Biological Sciences: Case Studies of Policy Challenges from New Technologies (Basic Bioethics)

Richard Allen Epstein — Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation

Jerry Avorn, M.D. — Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs

Marshall S. Shapo — Experimenting with the Consumer: The Mass Testing of Risky Products on the American Public

Mickey C. Smith, E. M. Kolassa, Walter S. Pray — Government, Big Pharma, and The People: A Century of Dis-Ease

Fran Hawthorne — Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat

Michael A. Santoro, Thomas M. Gorrie — Ethics and the Pharmaceutical Industry

David A. Dana — The Nanotechnology Challenge: Creating Legal Institutions for Uncertain Risks

Michael A. Santoro, Thomas M. Gorrie — Ethics and the Pharmaceutical Industry

Douglas Powell, William Leiss — Mad Cows and Mother's Milk: The Perils of Poor Risk Communication

Douglas Powell; William Leiss — Mad Cows and Mother's Milk: The Perils of Poor Risk Communication

Mickey C Smith — Pharmaceutical marketing: principles, environment, and practice

Thomas R. Fulda, Albert I. Wertheimer — Handbook of Pharmaceutical Public Policy

Paul Ruschmann — Prescription and Non-prescription Drugs (Point Counterpoint)

Kip W. Viscusi — Regulation through Litigation

W. Kip Viscusi — Regulation Through Litigation

Mary Graham — Democracy by disclosure. The rise of Technopopulism

Fred C. Pampel — Prescription Drugs

Henry I. Miller — To America's Health: A Proposal to Reform the Food and Drug Administration

Joseph Dumit — Drugs for Life: How Pharmaceutical Companies Define Our Health

Joseph Dumit — Drugs for Life: How Pharmaceutical Companies Define Our Health

Ching-Fu Lin, Kuei-Jung Ni, (eds.) — Food Safety and Technology Governance

Kuei-Jung Ni, Ching-Fu Lin — Food Safety and Technology Governance

Most frequently terms